Related Experiment Video
Updated: Jun 22, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Overview of pathogenesis of systemic sclerosis.
D J Abraham1, T Krieg, J Distler
1Centre for Rheumatology and Connective Tissue Disease, Royal Free and University College Medical School, University College London, Hampstead, London, UK. d.abraham@medsch.ucl.ac.uk
Rheumatology (Oxford, England)
|June 3, 2009
Summary
The exact cause of systemic sclerosis (SSc) is unknown, but research suggests it involves immune system dysfunction and endothelial cell damage. Endothelin-1 is a key factor in SSc vasculopathy, offering a potential therapeutic target.
Area of Science:
- Rheumatology
- Immunology
- Vascular Biology
Background:
- The etiology of Systemic Sclerosis (SSc) remains largely unknown, necessitating further research into its underlying mechanisms.
- SSc pathogenesis involves complex interactions between the endothelium, epithelium, fibroblasts, and immune systems, with dysregulated angiogenesis and vasculopathy observed across multiple organs.
Purpose of the Study:
- To elucidate the unclear etiological factors and pathogenic pathways in Systemic Sclerosis (SSc).
- To identify key mediators of vasculopathy in SSc for potential therapeutic interventions.
Main Methods:
- Review of current research on SSc etiology and pathogenesis.
- Analysis of the role of endothelial cell damage and angiogenesis in SSc.
- Examination of vasculopathy similarities across affected organs in SSc.
Main Results:
- Endothelial cell damage is a potential initiating factor in SSc, though the precise trigger is elusive.
- Dysregulated angiogenesis and shared vasculopathic features (e.g., pulmonary arterial hypertension, renal disease, digital ulcers) are characteristic of SSc.
- Endothelin-1 is identified as a potent mediator of SSc-related vasculopathy.
Conclusions:
- Understanding SSc etiology requires further investigation into initiating events.
- Endothelin-1 represents a significant therapeutic target for managing vascular manifestations in Systemic Sclerosis.
Related Concept Videos
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.